ZEISS Invests by Acquiring Majority Stake in arivis AG

ZEISS further expands its imaging technology capabilities for research microscopy with leading 3D and big image data software expertise

Jena / Munich, Germany | 7 December 2020 | ZEISS Research Microscopy Solutions

ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy. Both companies have a long-standing collaboration and strategic partnership, as arivis has been an important development partner for ZEISS for more than seven years.

ZEISS Invests by Acquiring Majority Stake in arivis AG © ZEISS
ZEISS Invests by Acquiring Majority Stake in arivis AG

"ZEISS is complementing its portfolio with highly innovative solutions and technologies that strengthen our leading position,” says Dr. Jochen Peter, member of the ZEISS Group Executive Board responsible for the Industrial Quality & Research segment, which includes the microscopy business. "This investment is in line with our strategy, which is focused on our customers' successes and the continuing expansion of our digital solutions.”

Dr. Michael Albiez, Head of ZEISS Research Microscopy Solutions, explains: "With this combination of the businesses, we are significantly developing our software competences further in the area of microscopy solutions for research especially when it comes to 3D image processing, visualization and analysis. Modern microscope systems with high-resolution optics are recording ever increasing amounts of data, and advanced software solutions help researchers to effectively analyze their data in a streamlined way, increasing their efficiency in research. Customers and users will benefit from the further integration of the software and hardware solutions from ZEISS and arivis.”

“This move brings our collaboration with ZEISS and arivis to a completely new level and takes a real long-term perspective. This will clearly help arivis to enable our customers to reach a new dimension in processing, displaying and analyzing the enormous growth and importance of image data,” says Andreas Suchanek, CEO and founder of arivis who will, together with the arivis team, drive the expansion of joint capabilities with ZEISS. Thus, Christian Götze will become Chief Technology Officer (CTO) of arivis.

The legal form of arivis AG will remain unchanged for the time being. All permanent employees of the imaging business of arivis will continue in their current positions. Both sides have agreed not to disclose the financial details of this transaction.

About arivis

arivis AG is a fast-growing, privately held software company providing imaging science solutions to researchers and enterprises engaged in all aspects of life science - from basic research and discovery to application. A broad product portfolio and range of expertise enables arivis to fulfill both industry and academic requirements. The products leverage innovative technologies to provide effective, efficient, and scalable applications and systems that solve problems at multiple levels in scientific organizations. arivis' customers include small to medium sized biotech companies, leading medical device and pharmaceutical companies, CROs and internationally renowned research organizations and universities. arivis is headquartered in Rostock (Germany) with further locations in Munich (Germany), London (United Kingdom) and Washington D.C. (United States). The company serves customers in more than 30 countries around the world.

Press Contact

Jörg Nitschke
Group Spokesman
ZEISS Group
Phone +49 7364 20-3242
joerg .nitschke @zeiss .com

www.zeiss.com/newsroom

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.

With over 31,000 employees, ZEISS is active globally in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

ZEISS Research Microscopy Solutions

ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen and Munich, as well as in Cambridge (UK) and Pleasanton (USA). ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.

Press Contact

Jörg Nitschke
Group Spokesman
ZEISS Group
Phone +49 7364 20-3242
joerg .nitschke @zeiss .com

www.zeiss.com/newsroom

Further Information
Share
Press Photos
ZEISS Invests by Acquiring Majority Stake in arivis AG
Further Articles

Winners of ZEISS Microscopy Image Contest Announced

Microscopy images from around 50 countries and various application areas submitted

ZEISS unveiled the winners of their ZEISS Microscopy Image Contest 2021. Microscope systems, analytics and imaging ca...

Sep 15, 2021

Resolve Biosciences and ZEISS Announce Co-Development Collaboration

Enhancing Highest-Resolution View of Subcellular Spatial Biology

Resolve Biosciences, the pioneer in Molecular Cartography™, and ZEISS announced a co-development collaboration to opt...

Aug 3, 2021

ZEISS Applies AI to 3D X-ray Microscope Reconstruction Technologies

New DeepRecon Pro and PhaseEvolve modules from ZEISS

Now available for the Advanced Reconstruction Toolkit (ART) on ZEISS Xradia 3D X-ray platforms, ZEISS DeepRecon Pro a...

Jul 28, 2021